angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with leucine in 3 studies
Studies (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Trials (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Recent Studies (post-2010) (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Studies (leucine) | Trials (leucine) | Recent Studies (post-2010) (leucine) |
---|---|---|---|---|---|
311 | 5 | 64 | 28,515 | 744 | 4,178 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ardaillou, R; Chansel, D; Czekalski, S; Ronco, P; Vandermeersch, S | 1 |
Li, Q; Pfaffendorf, M; van Zwieten, PA | 1 |
Albiston, AL; Chai, SY; Lew, RA; McDowall, SG; Mustafa, T; Ye, S | 1 |
3 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and leucine
Article | Year |
---|---|
Evidence for angiotensin IV receptors in human collecting duct cells.
Topics: Aminopeptidases; Angiotensin II; Angiotensin Receptor Antagonists; Binding, Competitive; Biphenyl Compounds; Blotting, Northern; Calcium; CD13 Antigens; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Imidazoles; Kidney Tubules, Collecting; Leucine; Losartan; Pyridines; Receptors, Angiotensin; RNA, Messenger; Tetrazoles | 1996 |
Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Anti-Bacterial Agents; Antihypertensive Agents; Biphenyl Compounds; Endothelium, Vascular; Femoral Artery; Imidazoles; In Vitro Techniques; Irbesartan; Leucine; Losartan; Male; Peptides; Protease Inhibitors; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Renal Artery; Tetrazoles; Vasoconstrictor Agents | 2001 |
Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).
Topics: Aminopeptidases; Angiotensin II; Angiotensin Receptor Antagonists; Binding, Competitive; Cell Line; Cystinyl Aminopeptidase; Enzyme Activation; Enzyme Inhibitors; Hemoglobins; Humans; Kidney; Leucine; Ligands; Oligopeptides; Peptide Fragments; Peptides; Receptors, Angiotensin; Recombinant Proteins; Substrate Specificity | 2003 |